Advances in oral immunomodulating therapies in relapsing multiple sclerosis

This review describes current treatment options, and recent developments for oral immunomodulating therapies in relapsing multiple sclerosis. It also highlights new oral compounds in late stage clinical development.

Source:

The Lancet Neurology